FibroBiologics, Inc (FBLG) insider trading

Every open-market stock purchase and sale by FibroBiologics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $121K over the last 12 months (5 buys).
  • Last insider buy: Hamid Khoja (C-suite exec), $11.4K, 7 months ago.

Last 12 months: insiders bought $121K (5 buys) and sold $0 (0 sales). Last close $1.03 on Jun 4, 2026.

Recent FBLG insider trades

DateInsiderTradeValue
Jun 23, 2026Robert E. Hoffman (Director)Bought (not open market)—
Jun 23, 2026Richard C. Cilento Jr. (Director)Bought (not open market)—
Jun 23, 2026Victoria Ninon Olivia Niklas (Director)Bought (not open market)—
Jun 23, 2026Matthew Link (Director)Bought (not open market)—
May 4, 2026Ruben A Garcia (General Counsel)Bought (not open market)—
May 4, 2026Pete O'Heeron (CEO)Bought (not open market)—
May 4, 2026Hamid Khoja (C-suite exec)Bought (not open market)—
May 4, 2026Jason Davis (CFO)Bought (not open market)—
Mar 4, 2026Hamid Khoja (C-suite exec)Bought$11.4K
Mar 4, 2026Pete O'Heeron (CEO)Bought$6K
Mar 3, 2026Pete O'Heeron (CEO)Bought$7.4K
Mar 2, 2026Jason Davis (CFO)Bought$29K
Mar 2, 2026Pete O'Heeron (CEO)Bought$6.2K
Feb 27, 2026Ruben A Garcia (General Counsel)Bought$13.1K
Dec 11, 2025Ruben A Garcia (General Counsel)Bought$47.6K

Who's trading FBLG

Get free alerts when an insider at FibroBiologics, Inc files a new trade →